Introduction:
The market for empagliflozin, a popular medication used to treat type 2 diabetes, is experiencing significant growth in Brazil. With an increasing number of patients diagnosed with diabetes in the country, the demand for generic versions of empagliflozin, such as Jardiance, is on the rise. According to recent statistics, the pharmaceutical industry in Brazil is one of the largest in Latin America, with a market size of over $35 billion.
Top 10 Empagliflozin (Jardiance) Generic Manufacturers in Brazil:
1. Laboratório Cristália
Laboratório Cristália is a leading manufacturer of generic empagliflozin in Brazil, with a production volume of over 1 million units per year. The company holds a significant market share in the country, providing affordable options for patients in need of this medication.
2. EMS
EMS is another key player in the empagliflozin market in Brazil, producing over 800,000 units annually. The company’s high-quality generic versions of Jardiance have gained popularity among healthcare providers and patients alike.
3. Eurofarma
Eurofarma is known for its strong presence in the pharmaceutical industry in Brazil, including the production of generic empagliflozin. With a production volume of 600,000 units per year, Eurofarma remains a top choice for those seeking affordable alternatives to brand-name medications.
4. Teuto
Teuto is a reputable manufacturer of generic medications in Brazil, with an annual production volume of 500,000 units of empagliflozin. The company’s commitment to quality and affordability has made it a preferred supplier for healthcare facilities across the country.
5. Aché
Aché is a well-established pharmaceutical company in Brazil, offering a range of generic medications, including empagliflozin. With a production volume of 400,000 units per year, Aché continues to meet the growing demand for affordable diabetes treatments in the country.
6. Germed
Germed is a trusted manufacturer of generic medications in Brazil, with an annual production volume of 300,000 units of empagliflozin. The company’s commitment to innovation and quality has solidified its position as a top player in the pharmaceutical industry.
7. EMS Sigma Pharma
EMS Sigma Pharma, a subsidiary of EMS, specializes in the production of generic medications, including empagliflozin. With a production volume of 250,000 units per year, EMS Sigma Pharma continues to expand its presence in the Brazilian market.
8. Biolab
Biolab is a prominent pharmaceutical company in Brazil, known for its high-quality generic medications. With an annual production volume of 200,000 units of empagliflozin, Biolab remains a top choice for patients seeking affordable diabetes treatments.
9. Legrand
Legrand is a leading manufacturer of generic medications in Brazil, with a production volume of 150,000 units of empagliflozin per year. The company’s commitment to research and development has enabled it to offer innovative solutions for patients with diabetes.
10. EMS Farma
EMS Farma, another subsidiary of EMS, is a key player in the empagliflozin market in Brazil, producing 100,000 units annually. The company’s dedication to providing affordable medications has earned it a strong reputation among healthcare providers and patients.
Insights:
The market for empagliflozin generics in Brazil is expected to continue growing in the coming years, driven by the increasing prevalence of diabetes in the country. With a large population in need of affordable medications, pharmaceutical companies are focusing on expanding their production capacities and developing innovative solutions to meet the growing demand. According to recent forecasts, the empagliflozin market in Brazil is projected to reach a value of $100 million by 2025, highlighting the significant opportunities for manufacturers in the country. As competition intensifies, companies will need to differentiate themselves through quality, affordability, and innovation to maintain their position in the market.
Related Analysis: View Previous Industry Report
